Novo Integrated Sciences, Inc. engages in the provision of medical services. The company is headquartered in Bellevue, Washington and currently employs 115 full-time employees. The company went IPO on 2005-07-12. The company operates through two reportable segments: healthcare services and product sales. Its businesses include healthcare, medical technology, manufacturing, research and diagnostics, and products and brands. Its specialized primary health care services include physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, and others. Its products include Terragenx and ProDip (dietary supplement pouches). Terragenx is a micro-dosing IoNovo Iodine product for all ages and lifestyles. Its medical technologies include telemedicine, and remote patient monitoring.
NVOS stock price ended at $0 on 星期二, after dropping 100.00%
On the latest trading day May 19, 2026, the stock price of NVOS fell by 100.00%, dropping from $0.02 to $0.00. During the session, the stock saw a volatility of Infinity%, with prices oscillating between a daily low of $0.00 and a high of $0.02. On the latest trading day, the trading volume for NVOS rose by 10.1K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 19.2K shares were traded, with a market value of approximately --.